HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (succinyl- beta- alanyl- L- leucyl- L- alanyl- L- leucyl)doxorubicin

structure in first source
Also Known As:
CPI-0004Na; CPI0004Na; N-suc-Ala-Leu-Ala-Leu-Dox
Networked: 5 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Trouet, A: 2 articles (11/2006 - 10/2001)
2. Dubois, V: 2 articles (11/2006 - 10/2001)
3. Dasnois, L: 2 articles (11/2006 - 10/2001)
4. Gangwar, S: 2 articles (11/2006 - 10/2001)
5. Trouet, André: 2 articles (07/2004 - 04/2002)
6. Lebtahi, Karim: 2 articles (07/2004 - 04/2002)
7. Dubois, Vincent: 2 articles (07/2004 - 04/2002)
8. Havaux, Nathalie: 2 articles (07/2004 - 04/2002)
9. Dasnois, Luc: 2 articles (07/2004 - 04/2002)
10. Yarranton, Geoffrey T: 2 articles (09/2003 - 04/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Prodrugs
3. Conditioned Culture Media

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Aftercare (After-Treatment)